{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T04:45:55Z","timestamp":1766551555467,"version":"3.37.3"},"reference-count":21,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:00:00Z","timestamp":1706659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["U01IP001144"],"award-info":[{"award-number":["U01IP001144"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.vaccine.2024.01.081","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T01:52:17Z","timestamp":1709085137000},"page":"1899-1905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Lyme disease vaccine attitudes and intentions among parents of children aged 5\u201318 years in the United States"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3561-8199","authenticated-orcid":false,"given":"Courtney","family":"Gidengil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4134-9300","authenticated-orcid":false,"given":"Aaron M.","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7511-0894","authenticated-orcid":false,"given":"Andrew M.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber","family":"Gedlinske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5607-6819","authenticated-orcid":false,"given":"Shannon","family":"Fleck-Derderian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison F.","family":"Hinckley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.","family":"Hook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8368-7375","authenticated-orcid":false,"given":"Megan C.","family":"Lindley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2393-6947","authenticated-orcid":false,"given":"Grace E.","family":"Marx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.vaccine.2024.01.081_b0005","doi-asserted-by":"crossref","first-page":"496","DOI":"10.15585\/mmwr.mm6717e1","article-title":"Vital signs: trends in reported vectorborne disease cases \u2013 United States and territories, 2004\u20132016","volume":"67","author":"Rosenberg","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2024.01.081_b0010","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3201\/eid2702.202731","article-title":"Estimating the frequency of Lyme disease diagnoses, United States, 2010\u20132018","volume":"27","author":"Kugeler","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2024.01.081_b0015","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3201\/eid2806.211335","article-title":"Economic burden of reported Lyme disease in high-incidence areas, United States, 2014\u20132016","volume":"28","author":"Hook","year":"2022","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2024.01.081_b0020","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3201\/eid2108.141878","article-title":"Geographic distribution and expansion of human Lyme disease","volume":"21","author":"Kugeler","year":"2015","journal-title":"United States Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2024.01.081_b0025","article-title":"Geographic expansion of Lyme disease in the southeastern United States, open forum","volume":"2015;2(4):ofv143","author":"Lantos","year":"2000","journal-title":"Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2024.01.081_b0030","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1177\/00333549211026777","article-title":"Changing trends in age and sex distributions of Lyme disease-United States, 1992\u20132016","volume":"137","author":"Kugeler","year":"2022","journal-title":"Public Health Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2024.01.081_b0035","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJM199807233390402","article-title":"A vaccine consisting of recombinant borrelia burgdorferi outer-surface protein a to prevent Lyme disease. recombinant outer-surface protein a Lyme disease vaccine study consortium","volume":"339","author":"Sigal","year":"1998","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2024.01.081_b0040","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199807233390401","article-title":"Vaccination against Lyme disease with recombinant borrelia burgdorferi outer-surface lipoprotein a with adjuvant. Lyme disease vaccine study group","volume":"339","author":"Steere","year":"1998","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2024.01.081_b0045","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1468-0009.2012.00663.x","article-title":"The rise and fall of the Lyme disease vaccines: a cautionary tale for risk interventions in american medicine and public health","volume":"90","author":"Aronowitz","year":"2012","journal-title":"Milbank Q"},{"key":"10.1016\/j.vaccine.2024.01.081_b0050","unstructured":"Pfizer Media Relations. Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15. https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-and-valneva-initiate-phase-3-study-lyme-disease. Accessed July 2, 2023."},{"key":"10.1016\/j.vaccine.2024.01.081_b0055","unstructured":"ClinicalTrials.gov. First Clinical Study of the Safety and Blood Levels of a Human Monoclonal Antibody (2217LS) Against Lyme Disease Bacteria in Healthy People. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04863287. Accessed July 2, 2023."},{"issue":"22","key":"10.1016\/j.vaccine.2024.01.081_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6622a1","article-title":"Surveillance for Lyme disease - United States, 2008\u20132015","volume":"66","author":"Schwartz","year":"2017","journal-title":"MMWR Surveill Summ"},{"issue":"5","key":"10.1016\/j.vaccine.2024.01.081_b0065","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/poq\/nfn065","article-title":"Computing response metrics for online panels","volume":"72","author":"Callegaro","year":"2009","journal-title":"Public Opin Q"},{"issue":"2","key":"10.1016\/j.vaccine.2024.01.081_b0070","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.vaccine.2021.11.065","article-title":"Evaluating public acceptability of a potential Lyme disease vaccine using a population-based, cross-sectional survey in high incidence areas of the United States","volume":"40","author":"Hook","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2024.01.081_b0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/000992280204100107","article-title":"Parental knowledge of and attitudes toward LYMErix (recombinant osp\u2013a Lyme vaccine)","volume":"41","author":"Barone","year":"2002","journal-title":"Clin Pediatr (Phila)"},{"issue":"11","key":"10.1016\/j.vaccine.2024.01.081_b0080","doi-asserted-by":"crossref","first-page":"e0274043","DOI":"10.1371\/journal.pone.0274043","article-title":"\u201cAll of the things to everyone everywhere\u201d: A mixed methods analysis of community perspectives on equitable access to monoclonal antibody treatment for COVID-19","volume":"17","author":"Kwan","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.01.081_b0085","unstructured":"Valneva. Valneva and Pfizer Report Positive Pediatric and Adolescent Phase 2 Booster Results for Lyme Disease Vaccine Candidate. https:\/\/valneva.com\/press-release\/valneva-and-pfizer-report-positive-pediatric-and-adolescent-phase-2-booster-results-for-lyme-disease-vaccine-candidate\/. Accessed September 29, 2023."},{"issue":"8","key":"10.1016\/j.vaccine.2024.01.081_b0090","doi-asserted-by":"crossref","first-page":"e2227437","DOI":"10.1001\/jamanetworkopen.2022.27437","article-title":"COVID-19 vaccination intentions, concerns, and facilitators among US parents of children ages 6 months through 4 years","volume":"5","author":"Scherer","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.vaccine.2024.01.081_b0095","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/her\/cyab032","article-title":"Understanding consumer and clinician perceptions of a potential Lyme disease vaccine","volume":"36","author":"Devchand","year":"2022","journal-title":"Health Educ Res"},{"issue":"6","key":"10.1016\/j.vaccine.2024.01.081_b0100","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4278\/0890-1171-20.6.379","article-title":"An evaluation of a Lyme disease prevention program in a working population","volume":"20","author":"Nolan","year":"2006","journal-title":"Am J Health Promot"},{"issue":"4","key":"10.1016\/j.vaccine.2024.01.081_b0105","first-page":"277","article-title":"Lyme disease knowledge, beliefs, and practices of New Hampshire primary care physicians","volume":"15","author":"Magri","year":"2002","journal-title":"J Am Board Fam Pract"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24001051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24001051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T10:40:22Z","timestamp":1714992022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24001051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0264410X24001051"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.01.081","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lyme disease vaccine attitudes and intentions among parents of children aged 5\u201318 years in the United States","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.01.081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 RAND Corporation. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}